Corindus Vascular Robotics (CVRS) Set to Announce Quarterly Earnings on Tuesday

Share on StockTwits

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) is scheduled to be announcing its earnings results after the market closes on Tuesday, November 6th. Analysts expect the company to announce earnings of ($0.05) per share for the quarter.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its quarterly earnings data on Tuesday, August 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%. The company had revenue of $1.67 million for the quarter, compared to the consensus estimate of $3.00 million.

Shares of NYSEAMERICAN CVRS traded up $0.05 during mid-day trading on Wednesday, reaching $1.01. 1,661 shares of the company were exchanged, compared to its average volume of 988,345. Corindus Vascular Robotics has a 52 week low of $0.66 and a 52 week high of $1.65.

In other Corindus Vascular Robotics news, Director Louis A. Cannon purchased 30,000 shares of the stock in a transaction on Wednesday, August 22nd. The stock was acquired at an average cost of $0.99 per share, with a total value of $29,700.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Louis A. Cannon purchased 31,000 shares of the stock in a transaction on Monday, August 13th. The stock was acquired at an average cost of $0.96 per share, with a total value of $29,760.00. The disclosure for this purchase can be found here. Insiders acquired 91,000 shares of company stock valued at $90,060 over the last three months.

A number of analysts have recently issued reports on CVRS shares. Zacks Investment Research raised shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a report on Monday, August 13th. Stifel Nicolaus downgraded shares of Corindus Vascular Robotics from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $3.00 to $1.00 in a report on Wednesday, August 8th.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Further Reading: How Do You Calculate Return on Investment (ROI)?

Earnings History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply